NO20015060L - Neurotrofinpotensiatorer - Google Patents

Neurotrofinpotensiatorer

Info

Publication number
NO20015060L
NO20015060L NO20015060A NO20015060A NO20015060L NO 20015060 L NO20015060 L NO 20015060L NO 20015060 A NO20015060 A NO 20015060A NO 20015060 A NO20015060 A NO 20015060A NO 20015060 L NO20015060 L NO 20015060L
Authority
NO
Norway
Prior art keywords
neurotrofinpotensiatorer
Prior art date
Application number
NO20015060A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015060D0 (no
Inventor
Fujio Isono
Miyuki Fujii
Atsushi Aoyagi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO20015060D0 publication Critical patent/NO20015060D0/no
Publication of NO20015060L publication Critical patent/NO20015060L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • C07D221/12—Phenanthridines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20015060A 1999-04-19 2001-10-18 Neurotrofinpotensiatorer NO20015060L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11076699 1999-04-19
PCT/JP2000/002534 WO2000063179A1 (fr) 1999-04-19 2000-04-19 Potentialisateurs de la neurotrophine

Publications (2)

Publication Number Publication Date
NO20015060D0 NO20015060D0 (no) 2001-10-18
NO20015060L true NO20015060L (no) 2001-12-18

Family

ID=14544047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015060A NO20015060L (no) 1999-04-19 2001-10-18 Neurotrofinpotensiatorer

Country Status (18)

Country Link
US (1) US20020119993A1 (xx)
EP (1) EP1172360A4 (xx)
JP (1) JP2001002572A (xx)
KR (1) KR20010112441A (xx)
CN (1) CN1356984A (xx)
AU (1) AU3839200A (xx)
BR (1) BR0009846A (xx)
CA (1) CA2370721A1 (xx)
CZ (1) CZ20013584A3 (xx)
HK (1) HK1039941A1 (xx)
HU (1) HUP0200866A3 (xx)
ID (1) ID30307A (xx)
IL (1) IL145867A0 (xx)
NO (1) NO20015060L (xx)
PL (1) PL351383A1 (xx)
TR (1) TR200103042T2 (xx)
WO (1) WO2000063179A1 (xx)
ZA (1) ZA200108419B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2330350A1 (en) 2000-12-05 2002-06-05 Chemokine Therapeutics Corporation Therapeutics for chemokine mediated diseases
AU2002215737A1 (en) * 2000-12-05 2002-06-18 Chemokine Therapeutics Corporation Tricyclic therapeutics for chemokine mediated diseases
CN102944674B (zh) * 2012-11-05 2014-10-22 武汉远征世纪制药有限公司 一种检测TrkB受体pan-Tyr位点活性的ELISA试剂盒及其使用方法
CN107082761B (zh) * 2017-04-17 2020-04-03 上海大学 菲啶酮或苯并菲啶酮衍生物及其合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID18046A (id) * 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
US20020022636A1 (en) * 1997-09-03 2002-02-21 Jia-He Li Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity
WO1999011644A1 (en) * 1997-09-03 1999-03-11 Guilford Pharmaceuticals Inc. Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity

Also Published As

Publication number Publication date
BR0009846A (pt) 2002-02-13
HUP0200866A2 (hu) 2002-07-29
EP1172360A1 (en) 2002-01-16
NO20015060D0 (no) 2001-10-18
KR20010112441A (ko) 2001-12-20
TR200103042T2 (tr) 2002-03-21
CN1356984A (zh) 2002-07-03
US20020119993A1 (en) 2002-08-29
CZ20013584A3 (cs) 2002-03-13
JP2001002572A (ja) 2001-01-09
HUP0200866A3 (en) 2003-02-28
PL351383A1 (en) 2003-04-07
ID30307A (id) 2001-11-22
AU3839200A (en) 2000-11-02
WO2000063179A1 (fr) 2000-10-26
EP1172360A4 (en) 2004-02-04
IL145867A0 (en) 2002-07-25
ZA200108419B (en) 2003-03-26
CA2370721A1 (en) 2000-10-26
HK1039941A1 (zh) 2002-05-17

Similar Documents

Publication Publication Date Title
DE50010505D1 (de) Gurtaufrollersystem
DE122007000064I2 (de) Erythropoietinkonjugate
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
DE50002834D1 (de) Handstempel
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE50015451D1 (de) Spülwannensystem
DE50009570D1 (de) Wechselcorrugator
DE50007953D1 (de) Beleuchtungsanordung
DE50008613D1 (de) Sicherungsring
DE50016100D1 (de) Gabtriebs
DE50000805D1 (de) Aufsitzspanner
DE50006899D1 (de) Antistatikum
DE10085008T1 (de) Oberflächenbehandlungsdüse
DE50003660D1 (de) Diacylhydrazinderivate
DE50012482D1 (de) Tibiamarknagel
DE50006013D1 (de) Anschlagpuffer
DE59906520D1 (de) Exzenterzahnradgetriebe
DE50003259D1 (de) Textilie
DE19983890T1 (de) Ventiltaktgebungsjustiereinrichtung
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE50008429D1 (de) Kraftstofffraktioniereinrichtung
DE50006759D1 (de) Piperidinalkohole
DE50009208D1 (de) Hydroxyphenylvinylthiazole

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application